Sickle Cell Care Expansion Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 21, 2022)
Sickle Cell Care Expansion Act of 2022
This bill establishes programs to increase treatment and other services for populations with sickle cell disease. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
Specifically, the Department of Health and Human Services must award grants to federally qualified health centers, community-based organizations, or other nonprofits that treat or otherwise support populations with sickle cell disease for education and advocacy programs concerning the disease.
Additionally, the Health Resources and Services Administration must establish a program to provide scholarships or student loan repayment awards to individuals who commit to engage in clinical practice or research related to sickle cell disease for a period of obligated service as physicians.
What just happenedMar 22, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 21, 2022
- Mar 22, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 21, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 21, 2022IntroReferralIntro-H
Introduced in House
- Mar 21, 2022IntroReferral1000
Introduced in House